NDA 091693 describes RAMELTEON, which is a drug marketed by
Actavis Labs Fl Inc,
Andas 5 Holding,
Aurobindo Pharma Ltd,
Dr Reddys Labs Sa,
Granules,
I3 Pharms,
Micro Labs,
Upsher Smith Labs,
Xiromed, and
Zydus Pharms, and is included in ten NDAs. It is available from
twenty-three suppliers. Additional details are available on the
RAMELTEON profile page.
The generic ingredient in RAMELTEON is
ramelteon. There are three
drug master file entries for this compound. Twenty-four
suppliers are listed for this compound. Additional details are available on the
ramelteon profile page.